Lifecore Biomedical Inc (LFCR) — 13F Holders Deep Dive (Q2 2026)

LFCR ranks #4533 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

LFCR is a top-conviction position for Legion Partners Asset Management, LLC — at 57.8% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in LFCR belongs to Wynnefield Capital Inc, but the position matters far more to Legion Partners Asset Management, LLC, who has 57.8% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

MassMutual Private Wealth & Trust, FSB has added to its LFCR position for two straight quarters, increasing it by $5.6K to reach $12.9K today.

GAMMA Investing LLC has trimmed its LFCR position for two straight quarters, cutting it by $425.0 while still holding $520.0.

LFCR is up 0.2% today, and institutions have been net buyers of $4.0M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

LFCR reported a net loss of $32.3M over the trailing twelve months.

• Not yet profitable — net loss of $32.3M over the trailing twelve months
• Revenue grew 10.5% year over year
• Net income improved year over year, from -$38.7M to -$32.3M
• Operating cash flow was negative, using $206.0K in cash
• Current ratio of 2.84x — enough short-term assets to cover short-term liabilities
• Liabilities run 143.64x equity — a highly leveraged balance sheet worth noting